SUDHIR AGRAWAL, D.Phil.

sudhir_large

Sudhir Agrawal, D. Phil, FRSC is a Visiting Professor in the Department of Medicine at The University of Massachusetts Medical School, and a member of the Business Advisory Board of The Harvard Medical School’s Initiative for RNA Medicine. He is founder and member of ARNAY Sciences LLC. He is also a founder of Idera Pharmaceuticals and has had held various leadership roles within the company, including Chairman, CEO, President of Research, and Chief Scientific Officer. Over the last three decades, his research has been focused on the discovery and development of nucleic acid therapeutics, including antisense technology. He has published over 300 research papers and is listed as a co-inventor of more than 400 patents worldwide. He has edited four books on oligonucleotides and antisense technology, including a recent book on ‘Advances in Nucleic Acid Therapeutics’ published in February 2019 by The Royal Society of Chemistry.